Atlas Trials

TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer

Clinical trial NCT04489173 · COMPLETED

Trial details

NCT number
NCT04489173
Sponsor
Borstkanker Onderzoek Groep
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast NeoplasmChemotherapy Effect
Start date
2020-09-25
Primary completion
2024-01-08
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.